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Introduction 
 
Through the process of natural selection, plants have evolved the 
ability to produce an array of defensive chemicals. Plant secondary 
metabolism, also termed specialized metabolism, represents a unique 
and vast pool of highly diversified molecules that qualitatively and 
quantitatively vary greatly within and between species [1]. While 
secondary metabolites are not directly involved in essential cellular 
functions, they play a major role in the adaptation of plants to their 
environment [2]. The impressive synthetic capacity of plants has long 
been exploited by mankind as a source of colorants, flavours, 
fragrances, traditional medicines and pharmaceutical drugs [3]. 
Presently, plant secondary metabolites represent valuable compounds 
for the pharmaceutical, cosmetic, agro-food, and fine chemicals 
industries [4].  
Among plant secondary metabolites, polyketides represent a large 
group of structurally diverse molecules. In plants, polyketides are 
synthesized by type III polyketide synthases (PKSs) by the 
condensation of acetyl (ketide) units with a coenzyme A (CoA)-
linked starter molecule [5]. The structural diversity of the plant 
polyketides results from the number of starter substrates that can be 
used by the PKSs and from subsequent modifications via regio-
specific condensation, cyclization, aromatization, hydroxylation, 
glycosylation, acylation, prenylation, sulfation, and methylation 
reactions [6]. Compound backbones generated by these PKSs include  
 
 
 
 
 
 
 
 
 
  
 
 
chalcones, stilbenes, phloroglucinols, resorcinols, benzophenones, 
biphenyls, bibenzyls, chromones, acridones, pyrones, and 
curcuminoids [7]. Some of the resulting plant polyketides have been 
shown to possess anticancer, antimicrobial, antiviral, antioxidant, 
neuroprotective and oestrogenic activities [8-12]. Such potential 
health-protecting effects of plant polyketides have stimulated the 
elucidation of their biosynthetic pathways and the development of 
frameworks for commercial production. 
For industrial or pharmaceutical applications, the use of plant 
polyketides is mainly limited by their availability [13]. Significant 
engineering work has been carried out in recent years to increase the 
yield of polyketides (mainly chalcones and stilbenes) in plants 
[14,15]. As is the case for other plant metabolites, many polyketides 
tend to accumulate in small amounts and may require long growth 
periods to do so [16]. Purification can also be problematic, as 
multiple structurally similar metabolites are often present [17]. Total 
or semi-synthetic approaches are generally challenging and may result 
in racemic mixtures with relatively low yields [18,19].  
Alternatively, microbes can be utilized as heterologous hosts for 
polyketides biosynthesis, with several advantages compared to plant 
and chemical synthesis. Microbes can be grown on inexpensive 
substrates and have very fast production cycles compared to plants. 
Current production methods result in microbial synthesis being 
significantly more environmentally friendly than chemical synthesis. 
Reconstruction of a plant biosynthetic pathway in microbes is still a 
challenging task. It first requires the stable introduction of multiple 
heterologous genes in the microbial host. These genes then have to be 
expressed and generate functional enzymes. Once functionality of the 
heterologous pathway has been demonstrated, the main challenge 
remains in reaching yields sufficient for commercialisation. 
This review presents the recent development of microbial 
engineering for the biosynthesis of plant polyketides, yield 
improvement and product diversification. Current limitations and 
bottlenecks are also covered. 
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Polyketide biosynthesis in plants 
 
Polyketides are a large group of metabolites found in bacteria, 
fungi and plants, which are synthesized from acyl-CoA precursors by 
PKS [20]. PKSs can be grouped in three distinct classes based on their 
biochemical features and product structure [21]. Type I refers to large 
modular and multifunctional enzymes, whereas type II PKSs are 
dissociable complexes usually composed of monofunctional enzymes 
that are found in bacteria [22]. Plant PKSs are part of the type III 
group, which comprises homodimeric enzymes of relatively small size 
[7]. Type III PKSs are also found in bacteria [23] and fungi [24]. 
Type III PKSs catalyze iterative decarboxylative condensations of 
malonyl units with a CoA-linked starter molecule [25]. A typical type 
III PKS reaction involves the loading of a starter molecule, the 
extension of the polyketide chain and cyclization of the linear 
intermediate [5]. A great variety of CoA-linked starter substrates can 
be utilized by plant type III PKSs: acetyl-CoA, malonyl-CoA, methyl-
malonyl-CoA, p-coumaroyl-CoA, cinnamoyl-CoA, N-
methylanthraniloyl-CoA, n-hexanoyl-CoA, isobutyryl-CoA, 
isovaleryl-CoA and 3-hydroxybenzoyl-CoA to name a few [5,7]. 
Chalcone synthase (CHS) is the archetypal plant-specific type III 
PKSs that catalyzes sequential condensation of p-coumaroyl-CoA 
with three molecules of malonyl-CoA to produce naringenin chalcone 
via a Claisen cyclization reaction (Fig. 1) [26]. Synthesis of p-
coumaroyl-CoA requires the action of three enzymes. Phenylalanine 
ammonia lyase (PAL) catalyses the first reaction of the 
phenylpropanoid pathway by the deamination of phenylalanine into 
trans-cinnamic acid [27]. A cinnamate 4-hydroxylase (C4H) then 
catalyses the hydroxylation of trans-cinnamic acid to yield p-coumaric 
acid [28]. Alternatively, p-coumaric acid can be produced directly 
from tyrosine by a tyrosine ammonia lyase (TAL), bypassing the C4H 
intermediate [6]. While some PALs have demonstrated promiscuity 
towards tyrosine, distinct TALs are found in grasses and non-plant 
organisms [29]. A 4-coumaroyl:CoA ligase (4CL) activates p-
coumaric acid through the addition of a CoA unit to generate p-
coumaroyl-CoA. These three enzymes, PAL, C4H and 4CL, are 
required for normal growth and development and, are therefore highly 
conserved among plants. A significant fraction of p-coumaroyl-CoA is 
consumed for lignin synthesis, but it is also required for flavonoid 
production [30]. Phenylpropanoid pathway intermediates are also 
redirected into synthesis of benzoates, salicylates, coumarins, 
monolignols, lignans, and phenylpropenes [29]. The other CHS co-
substrate, malonyl-CoA, is formed by the carboxylation of acetyl-
CoA, a reaction catalyzed in the cytosol by a homomeric acetyl-CoA 
carboxylase (ACC) [31]. Malonyl-CoA is also required for the 
synthesis of fatty acids, but is produced in the plastid by a distinct 
ACC for this purpose [32]. After formation of naringenin chalcone 
(also called chalconaringenin) by CHS, a variety of flavonoids are 
created by the combined actions of functionalizing enzymes, namely 
isomerases, reductases, hydroxylases, glycosyltransferases, 
acyltransferases, methyltransferases and prenyltransferases [19,29,33]. 
Stilbene synthase (STS), another well studied representative of the 
plant type III PKSs, uses the same substrates as CHS, but performs an 
aldol cyclization reaction to produce resveratrol  [34] (Fig. 1). STS is 
found in few diverse plants, such as grapevine, and would have 
evolved from CHS by a limited number of amino acids substitutions 
[35].  
Figure 1. Naringenin chalcone and resveratrol common biosynthetic pathway. TAL, tyrosine ammonia lyase; PAL, phenylalanine ammonia lyase; C4H, 
cinnamate 4-hydroxylase; 4CL, 4-coumaroyl:CoA ligase; ACC, acetyl-CoA carboxylase; CHS, chalcone synthase; STS, stilbene synthase. 
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Figure 2. Examples of plant polyketides. 
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Naringenin chalcone and resveratrol are not the only plant 
polyketides that can result from the condensation of p-coumaroyl-
CoA and malonyl-CoA. Different polyketides can be synthesised by 
varying the number of malonyl-CoA and p-coumaroyl-CoA molecules 
used in the elongation step (Fig. 2). The type of cyclization or its 
absence also influences the resulting product [7]. Styrylpyrone 
synthase (SPS) produces bisnoryangonin from the condensation of 
two molecules of malonyl-CoA [36]. Benzalacetone synthase (BAS) 
catalyzes the condensation of only one molecule of malonyl-CoA 
without a cyclization, resulting in diketide benzalacetone [37]. 
Similarly, curcuminoid synthase (CUS) uses one molecule of malonyl-
CoA without cyclization, but produces bisdemethoxycurcumin by the 
condensation with p-coumaroyl-CoA [38]. Other plant PKSs catalyze 
the condensation of three malonyl-CoA units while employing varying 
starter substrates. Such PKSs include acridone synthase (ACS), 
phlorisovalerophenone synthase (VPS), benzophenone synthase 
(BPS), olivetol synthase (OLS) and 2-pyrone synthase (2PS) [7].  
 
Engineered microbes 
 
Like many plant secondary metabolites, polyketides are often 
difficult to extract in large amounts or to synthesize chemically. For 
those reasons, engineering microbes for the production of plant 
metabolites is emerging as an advantageous alternative. This approach 
typically required the construction of new metabolic pathways in the 
microbial host and the modification of existing ones to enhance 
productivity. Metabolic engineering for plant polyketide production 
has been conducted mainly in the two workhorse organisms 
Escherichia coli and Saccharomyces cerevisiae. These two microbial 
hosts are easy to grow and manipulate, are genetically and 
biochemically well characterized, and have many genetic tools 
available. As a eukaryote, S. cerevisiae presents some distinct 
advantages over E. coli for the reconstruction of plant pathways. S. 
cerevisiae has compartments similar to plant cells and can post-
translationally modify proteins. The eukaryotic cellular environment 
is also more adequate for the expression of functional membrane 
proteins, such as cytochrome P450s.  
E. coli and S. cerevisiae naturally produce malonyl-CoA, but lack 
most of the CoA-ester starter substrates needed for plant polyketide 
synthesis. Although precursors can be supplemented in the growth 
medium, the production of these substrates represents an important 
part of the microbe engineering process. Most plant polyketide 
pathway engineering in microbes described in the literature is based 
on CHS and STS, with only few other examples using curcuminoid 
synthase and tetraketide synthase (Table 1).  
 
Chalcone synthases 
 
Hwang et al. [39] were the first to report the production of plant 
polyketides in E. coli. Naringenin and pinocembrin were produced by 
co-expressing PAL from the yeast Rhodotorula rubra, 4CL from the 
actinobacterium Streptomyces coelicolor A3(2), and CHS from the 
plant Glycyrrhiza echinata. PAL could use both tyrosine and 
phenylalanine as substrates, yielding p-coumaric acid and trans-
cinnamic acid, respectively. Similarly, 4CL catalyzed the activation of 
trans-cinnamic and p-coumaric acid, and CHS used both cinnamoyl- 
CoA and p-coumaroyl-CoA as starters. Very small amounts of 
naringenin (0.27 µg/L) and pinocembrin (0.17 µg/L) were detected 
in the culture medium. To increase yields, tyrosine and phenylalanine 
were supplemented. As a result, yields of naringenin and pinocembrin 
were increased to 452.6 µg/L and 751.9 µg/L, respectively. The 
same group was then able to improve production of naringenin and 
pinocembrin by overexpressing an ACC from Corynebacterium 
glutamicum and by optimising culture conditions [41]. They also 
added a chalcone isomerase from Pueraria lobata to catalyze the 
isomerisation of naringenin chalcone to naringenin. Although the 
malonyl-CoA concentrations were not reported, these results 
suggested that an increase in the amount of malonyl-CoA, as a result 
of ACC overexpression, led to improved production of polyketides. 
Under culture conditions where E. coli cells were concentrated to 50 
g/L, yields of naringenin and pinocembrin reached about 60 mg/L in 
the presence of tyrosine and phenylalanine, respectively. Watts et al. 
[40] were the first to use a true TAL enzyme from the bacteria 
Rhodobacter sphaeroides. This enzyme, while accepting both tyrosine 
and phenylalanine as substrates, exhibits a much higher specificity 
toward tyrosine [66]. By using TAL, p-coumaric acid was efficiently 
produced directly from tyrosine without producing trans-cinnamic 
acid and pinocembrin. 
Jiang et al. [54] first described the production of naringenin and 
pinocembrin in S. cerevisiae. This was accomplished by the combined 
expression of PAL from the red yeast Rhodosporidium toruloides, 
4CL from Arabidopsis thaliana, and CHS from the plant Hypericum 
androsaemum. As described by Miyahisa et al. [41], PAL showed 
tyrosine ammonia lyase activity, which enabled the biosynthesis of 
naringenin without the need of C4H. Precursor feeding studies 
indicated that the tyrosine pool size limited p-coumaric acid 
production, although no additional naringenin could be produced.  
Yan et al. [55] opted for a different approach, using four plant-
derived genes : C4H from Arabidopsis thaliana, 4CL from 
Petroselinum crispum, CHS and chalcone isomerase (CHI) from 
Petunia × hybrida. Feeding assays were done with trans-cinnamic 
acid, p-coumaric acid, caffeic acid, and ferulic acid, yielding 
respectively pinocembrin (16.3 mg/L), naringenin (28.3 mg/L), 
eriodictyol (6.5 mg/L), but no homoeriodictyol. However, 
naringenin yield was quite low (0.2 mg/L) when trans-cinnamic acid 
was the precursor, indicating that C4H was a rate-limiting step. In a 
follow-up study, the same group tested two flavone synthases (FSI 
and FSII) in their yeast strain harbouring C4H, 4CL, CHS, and CHI 
[56]. The resulting strains converted fed phenylpropanoid acid 
precursors into the flavone molecules chrysin, apigenin, and luteolin. 
Yields were increased by overexpressing the yeast cytochrome P450 
reductase (CPR1) and by using acetate as carbon source. CPR1 
overexpression probably improved both C4H and FSII activities. The 
overall increase in flavone production with acetate was hypothesized 
to result from increased carbon flux toward malonyl-CoA. Leonard et 
al. [44] also evaluated flavone production in E. coli, using 4CL and 
FSI from Petroselinum crispum, CHS and CHI from Petunia x 
hybrida, and 7-O-methyltransferase (OMT) from Mentha x piperita. 
E. coli successfully produced apigenin, luteolin and genkwanin from 
fed phenylpropanoid acid precursors. 
Results from Miyahisa et al. [41] and Leonard et al. [56] 
indicated that malonyl-CoA was most probably limiting polyketide 
production in E. coli and S. cerevisiae. Leonard et al. [45] explored 
various strategies to increase the intracellular pool of malonyl-CoA in 
E. coli. Overexpression of four ACC subunits from the bacteria 
Photorhabdus luminescens resulted in an increase in flavone 
production, especially for pinocembrin. Due to ACC being a biotin-
dependent enzyme, yields were further increased by combining 
expression of ACC with a biotin ligase (BL). Three BLs were tested, 
one from P. luminescens, one from E. coli, and a fusion of those two. 
The co-expression of ACC and BL from P. luminescens gave the best 
result. In another approach, flux toward malonyl-CoA was increased 
through the amplification of acetate assimilation. Culture medium was 
supplemented with acetate in addition to glucose, and acetyl-CoA 
synthetase (ACS) from E. coli was overexpressed along with ACC. 
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ACS catalyses the formation of acetyl-CoA from acetate and CoA. 
With this last approach, pinocembrin, naringenin, and eriodictyol 
accumulated in the culture medium to 429 mg/L, 119 mg/L, and 52 
mg/L, respectively. 
Leonard et al. [47] used a more elaborate metabolic engineering 
approach for producing flavanones from exogenous phenylpropanoid 
acids in E. coli. To increase availability of malonyl-CoA, a malonyl-
CoA synthetase (MatB) and a putative malonate transporter (MatC) 
from the bacteria Rhizobium trifolii were introduced in E. coli. MatB 
and MatC allowed the production of malonyl-CoA from exogenous 
malonate, bypassing the natural metabolism from glucose. The 
introduction of this malonate assimilation pathway increased 
production of naringenin, pinocembrin and eriodictoyl by 269%, 
1555% and 355%, respectively. Yields were further increased by 
attenuating the activity of fatty acid metabolism, which competes for 
malonyl-CoA. This was done by adding a fatty acid synthase inhibitor 
to the culture medium.  
Park et al. [65] reported the first plant-derived polyketide 
production in an organism other than E. coli and S. cerevisiae. Genes 
encoding 4CL from Streptomyces coelicolor and CHS from A. 
thaliana were expressed in Streptomyces venezuelae. Relatively small 
amounts of naringenin (4 mg/L) and pinocembrin (6 mg/L) were 
produced when fed with p-coumaric acid and trans-cinnamic, 
respectively.  
In most of the strategies described previously, polyketide 
production required supplementation of precursors. Santos et al. [13] 
engineered a four-step pathway consisting of a TAL, 4CL, CHS, CHI 
in a tyrosine-overproducing E. coli strain, allowing naringenin 
production directly from glucose. Enzymes from different sources 
were tested, and genes were codon-optimized for E. coli expression. 
The performance of TAL from R. sphaeroides (RsTAL) and from 
the yeast Rhodotorula glutinis (RgTAL) was evaluated in the absence 
of the other downstream enzymes. Only small amounts of p-coumaric 
acid (1.5-5.5 mg/L) were produced with RsTAL compared to 
RgTAL (104-213 mg/L). Enzymatic assays with purified enzymes 
revealed a twelve-fold higher catalytic activity with tyrosine for 
RgTAL [66]. Different 4CLs, CHSs and CHIs were also evaluated. 
The most efficient strain was obtained with RgTAL, 4CL from 
Petroselinum crispum, CHS from Petunia hybrida and CHI from 
Medicago sativa L. Without any precursor supplementation, the 
strain was capable of producing 29 mg/L of naringenin and up to 84 
mg/L with the addition of cerulenin, a fatty acid enzyme inhibitor. 
Choi et al. [49] also reported the production of naringenin in E. coli 
without feeding tyrosine or p-coumaric acid. Their synthetic gene 
cluster was composed of TAL from Saccharothrix espanaensi, 4CL 
from S. coelicolor and CHS from A. thaliana. The yield of naringenin 
obtained (5.3 mg/L) was low compared to Santos et al. [13], as no 
further metabolic engineering was done to improve precursors level.         
With the aim to improve the availability of malonyl-CoA in E. 
coli, Xu et al. [50] used an integrated computational and experimental 
approach. A customized version of the OptForce algorithm  was 
utilized to predict a minimal set of metabolic interventions [67]. 
Based on that model, genes encoding a fumarase (fumC) and a 
succinyl-CoA synthetase (sucC) were knocked out. FumC and SucC 
are part of the TCA cycle and catalyze the interconversion of 
fumarate to malate and the reversible reaction of succinyl-CoA to 
succinate, respectively. Knocking out those genes partially inactivated 
the TCA cycle, which in turn increased naringenin production by 
30% compared to the wild type strain. The model also identified 
target genes that if upregulated would augment the production of the 
precursor acetyl-CoA. By co-expressing acetyl-CoA carboxylase 
(ACC) with either phosphoglycerate kinase (PGK) or glyceraldehyde-
3-phosphate dehydrogenase (GAPD), and pyruvate dehydrogenase 
(PDH), production of naringenin was increased by about 220%. 
Finally, overexpression of ACC, PGK and PDH in the double 
knockout strain resulted in the production of 474 mg/L of 
naringenin, the highest yield achieved so far. 
Koopman et al. [64] were the first to engineer S. cerevisiae for 
improved tyrosine availability for the production of naringenin. 
Synthesis of tyrosine was increased by introducing a feedback resistant 
3-deoxy-d-arabinose-heptulosonate-7-phosphate (DAHP) synthase 
allele (ARO4G226S) and deleting the other allele (ARO3). 
Additionally, the loss of tyrosine to side products was reduced by 
deleting the phenylpyruvate decarboxylases (Aro10, Pdc5, Pdc6). 
Most of the naringenin biosynthetic pathway parts (PAL, C4H, CPR, 
4CL, CHS, CHI) were from A. thanliana, but a TAL from R. 
capsulatus was also used. The presence of PAL, C4H, CPR and TAL 
allowed synthesis of p-coumaric acid from both tyrosine and 
phenylalanine. In shake-flask cultures, approximately 50 mg/L of 
naringenin was produced directly from glucose and, more than 100 
mg/L in controlled aerobic batch cultures.   
Wu et al. [52] engineered E. coli to increase both the supply of 
phenylalanine and malonyl-CoA. Carbon flux toward phenylalanine 
was increased by overexpressing 3-deoxy-d-arabinose-heptulosonate-
7-phosphate (AroF) and a feedback-inhibition-resistant chorismate 
mutase/prephenate dehydratase (PheA). The supply of malonyl-CoA 
was increased by introducing the malonate assimilation pathway from 
R. trifolii (MatB and MatC), as described previously by Leonard et al. 
[47]. The resulting strain, in which TAL (R. glutinis), 4CL (P. 
crispum), CHS (P. × hybrida) and CHI (M. sativa) were co-
expressed, allowed the production of pinocembrin (40 mg/L) 
without any precursor supplementation.        
 
Stilbene synthases 
 
Becker et al. [53] were the first to report the production of 
resveratrol in an engineered microorganism. The resveratrol (1.45 
µg/L) was produced in S. cerevisiae from fed p-coumaric acid by co-
expressing 4CL from Populus trichocarpa × Populus deltoides and 
STS from Vitis vinifera. Zhang et al. [57] further improved 
resveratrol yield in S. cerevisiae by fusing 4CL from A. thaliana and 
STS from V. vinifera. The 4CL::STS fusion protein increased 
resveratrol production by up to 15-fold compared to the co-
expression of 4CL and STS. Nevertheless, the yield of resveratrol 
(5.25 mg/L) obtained from p-coumaric acid feeding remained 
relatively low. In E. coli, resveratrol was produced at a higher level. 
Concentrations reached 16 mg/L by co-expressing 4CL from 
Nicotiana tabacum and STS from V. vinifera [43], and over 100 
mg/L when co-expressing 4CL from A. thaliana and STS from 
Arachis hypogaea [42]. A similar two-reaction approach was used in 
S. venezuela with a 4CL from S. coelicolor and a STS from A. 
hypogaea, producing 0.4 mg/L of resveratrol [65]. Trantas et al. [58] 
extended the synthetic pathway in S. cerevisiae by adding a PAL and a 
CPR from Populus trichocarpa x P. deltoides and a C4H from 
Glycine max. This extended pathway synthesized resveratrol from fed 
phenylalanine, but with a yield of less than 1 mg/L. Sydor et al. [59] 
evaluated resveratrol synthesis from p-coumaric acid in different S. 
cerevisiae strains expressing 4CL from A. thaliana and STS from V. 
vinifera. Different growth media were also tested. In synthetic 
medium (SD), the strain CEN.PK2-1 produced 6 mg/L of 
resveratrol. When grown in the rich medium YEPD, yield increased 
dramatically to 262 mg/L. They also evaluated four industrial yeast 
strains for their efficiency in resveratrol production. Three strains 
produced resveratrol in various concentrations, but one metabolized 
p-coumaric acid and did not synthesis any resveratrol. The highest 
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yield (391 mg/L) was obtained with an S. cerevisiae strain isolated 
from a Brazilian sugar cane plantation. Other attempts to produce 
resveratrol in E. coli and S. cerevisiae have resulted in yields not 
exceeding 6 mg/L [49,60,61,63].  
 
Curcuminoid synthase 
 
Curcuminoid synthase (CUS) is a type III PKS involved in the 
formation of diarylheptanoid compounds, such as those found in the 
spice turmeric [68]. An artificial curcuminoid biosynthetic pathway 
based on a CUS from rice (Oryza sativa) was assembled in E. coli 
[48]. CUS catalyzes the formation of bisdemethoxycurcumin from 
two molecules of p-coumaroyl-CoA and one molecule of malonyl-
CoA [68]. It also accepts cinnamoyl-CoA and feruloyl-CoA as 
substrates to produce dicinnamoylmethane and curcumin, respectively. 
Along with CUS, a PAL from R. rubra and a 4CL from 
Lithospermum erythrorhizon were assembled in E. coli. The resulting 
strain produced bisdemethoxycurcumin (53.4 mg/L), 
dicinnamoylmethane (107 mg/L) and cinnamoyl-p-
coumaroylmethane (19.2 mg/L) from supplemented tyrosine and/or 
phenylalanine. Curcumin (113 mg/L) was also synthesised when 
ferulic acid was fed.  
 
Tetraketide synthase and olivetolic acid cyclase 
 
Gagne et al [62] have recently reported the identification of a 
novel polyketide cyclase enzyme, olivetolic acid cyclase (OAC), which 
functions together with a type III PKS to form olivetolic acid using 
hexanoyl-CoA as a starter substrate. Olivetolic acid is the first 
polyketide intermediate in the cannabinoid biosynthetic pathway in 
Cannabis sativa (marijuana, hemp). Co-expression of a type III PKS 
from cannabis, dubbed tetraketide synthase (TKS) based on its 
presumed synthesis of a linear tetraketide, and OAC in yeast that was 
supplied with exogenous hexanoic acid allowed for the production of 
small amounts of olivetolic acid (0.48 mg/L). Further optimization 
of precursor supply, including the use of hexanoyl-CoA synthetases 
[69] to augment the supply of the starter substrate, may allow 
increased yield of this alkylresorcinolic product. 
 
Limitations and bottlenecks  
 
As with other secondary metabolites, achieving high yields of 
plant polyketides in microbes is a challenging task. An array of factors 
can impair productivity. The most obvious include the functionality 
of the biosynthetic pathway and the availability of precursors. The 
efficacy of a heterologous pathway is first affected by the 
concentration of its constituent enzymes. Although transcription rate 
can impact gene expression, there is no general correlation between 
mRNA and protein abundance [70-72]. Enzyme concentration is also 
influenced by translation-related mechanisms and protein degradation 
rate [73]. Codon usage is known to affect heterologous gene 
expression [74,75].  Although codon optimization does not 
necessarily improve expression, it should be part of every metabolic 
engineering approach. In addition to expression, enzyme efficiency 
(kcat/KM) can affect final productivity. Enzyme stability in the 
heterologous host, cofactor requirements, post-translational 
modification and regulation, subcellular compartmentation and 
feedback inhibition are other factors to consider. If possible, multiple 
enzymes should be tested to find the best candidates for each step of 
the pathway. In plants, polyketide pathways are tightly regulated so 
that only the required quantities of metabolites are produced [76]. In 
contrast, synthetic pathways assembled in heterologous hosts are not 
under such regulatory control. This absence of regulation can lead to 
growth retardation and may cause accumulation of toxic 
intermediates. Modulating expression of relevant genes is a commonly 
used strategy for balancing pathway dynamics. This can be done by 
tuning promoter strengths, by manipulating non-coding regions, and 
by altering gene or plasmid copy number [77-79]. Rate-limiting 
enzymes can be substituted for more efficient ones or can be 
improved by protein engineering [80,81].  
The productivity of a synthetic pathway is greatly determined by 
the supply of precursor metabolites. As demonstrated by multiple 
research groups, tyrosine/phenylalanine and malonyl-CoA are 
limiting for the production of polyketides in microbes 
[39,41,45,47,50,54]. Although tyrosine and phenylalanine can be 
supplemented in the growth medium, this is not a sustainable option 
for cost-effective polyketide production. A more viable alternative is 
to increase the pool of tyrosine/phenylalanine within the polyketide-
producing host, an approach successfully used by Santos et al. [13]. 
Different groups succeeded in increasing tyrosine production in E. 
coli and S. cerevisiae by overproducing feedback-inhibition-resistant 
enzymes from the aromatic amino acid biosynthesis pathway and by 
removing transcriptional regulation [82-85]. Santos et al. [86] 
subsequently improved the tyrosine titer in E. coli by using a global 
transcription machinery engineering approach (gTME) [87]. A 
common approach to increase the pool of malonyl-CoA is to 
overexpress ACC, the enzyme that catalyzed its synthesis from acetyl-
CoA [41,45,63,88]. Malla et al. [51] also included an acetyl-CoA 
synthetase to increase the carbon flux toward malonyl-CoA. 
Alternatively, malonyl-CoA can be synthesised from malonate by the 
co-expression of a malonyl-CoA synthetase (MatB) and a putative 
dicarboxylate carrier protein (MatC) from Rhizobium trifolii, a 
strategy succesfully used in E. coli [47]. More sophisticated 
engineering approaches, that included the overexpression and the 
knockout of multiple genes, were also used to increase the pool of 
malonyl-CoA [50,89,90].  
 
Combinatorial biosynthesis of novel, unnatural plant type III 
polyketides 
 
Type III polyketides are of particular interest due to their 
potential as bioactive compounds with therapeutic uses. When 
screening for desired functionalities, the larger the library of diverse 
compounds one can create, the higher the chances of finding a 
compound that can fulfill a purpose of interest. In addition to the role 
of the type III PKSs, the diversity of plant polyketides also arises from 
the range of tailoring enzymes that perform post-polyketide 
modifications [91]. Because of this, the use of combinatorial 
biosynthesis is an ideal way to increase variety in an ever expanding 
library of polyketides derived from type III PKSs. Combinatorial 
biosynthesis entails designing artificial biosynthetic pathways 
containing enzyme-encoding genes from different species and/or 
organisms into a heterologous host. In this way, PKSs can be 
combined with tailoring enzymes from other organisms resulting in 
polyketides that would otherwise never be formed. 
In 1999 McDaniel et al. [92] were able to create a library of over 
50 unnatural products (macrolides) by genetically modifying the 
erythromycin PKS genes thereby combinatorially affecting their 
catalytic activities in the biosynthetic pathway. Five years later, 
Katsuyama et al. [46] used combinatorial biosynthesis and precursor-
directed biosynthesis to create novel plant polyketides. This required 
a multi-plasmid approach, transforming E. coli with three plasmids 
each containing three distinct sections of the polyketide biosynthetic 
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pathway. The first plasmid (substrate synthesis plasmid) contained 
4CL from Lithospermum erythrohizon. The second plasmid 
(polyketide synthesis plasmid) contained CHS from Glycyrrhiza 
echinata and CHI genes from Pueraria lobata, or contained the STS 
gene from Arachis hypogaea. The post-polyketide modification 
plasmid contained either genes for flavone (FNS I gene from 
Petroselinum crispum) or flavonol production (flavanone 3β-
hydroxylase (F3H) and flavonol synthase (FLS) genes from Citrus).  
The various genes from various organisms used to create this pathway 
define the combinatorial biosynthesis aspect of this experiment. 
Precursor-directed biosynthesis is a technique where cells are supplied 
with unnatural precursors which result in the formation of unnatural 
products. Natural and unnatural carboxylic acids were also 
exogenously introduced to the recombinant E. coli. When natural 
carboxylic acids were introduced, the system created corresponding 
natural polyketides. When unnatural carboxylic acids were 
introduced, the organism mainly produced the corresponding 
unnatural polyketides. The authors hypothesized that the reason for 
this was the relatively relaxed substrate specificity of their FNS I. This 
system resulted in the synthesis of 14 flavanones, 13 flavones, 8 
flavanols, and 15 stilbenes at high yields and, the production of 20 
triketide pyrones and 17 tetraketide pyrones through derailment or 
incorrect cyclization. Out of the 50 polyketides, 36 were novel 
compounds. 
Also in 2007, Chemler et al. [93] were able to create a type III 
polyketide pathway in Saccharomyces cerevisiae capable of utilizing 
acrylic acid analogues to produce novel unnatural polyketides. In this 
study, acrylic acid analogues were first screened in vitro for their 
potential as substrates for the flavonoid enzymes. In the second-stage 
screening, the compounds were tested for their ability to be 
synthesized into flavanone analogues through an in vitro assay where 
4CL, CHS and CHI from petunia and a malonyl-CoA synthetase 
from Rhizobium trifolii were provided. The acrylic acids that passed 
both screenings were then provided as substrates for a S. cerevisiae 
strain expressing 4CL, CHS and CHI on a plasmid. This system 
resulted in the expression of six unnatural flavanones. In an effort to 
increase the amount of novel flavonoids produced, a plasmid 
containing flavanone 3β-hydroxylase (FHT) from Malus domestica 
was added to the initial strain, creating six novel dihydroflavonols 
from 6 acrylic acids. 
Another interesting approach to the formation of novel polyketide 
compounds is the manipulation or mutation of the type III PKS 
protein itself. In 2007, Abe et al. [94] mutated the pentaketide 
chromone synthase (PCS) from Aloe arborescens in order to create 
novel polyketides. E. coli expressing a triple mutant 
(F80A/Y82A/M207G) version of PCS, using malonyl-CoA as a 
substrate, was found to lead to the production of an unnatural novel 
nonaketide (naphthopyrone). In addition, control over polyketide 
chain length from triketide to octaketide has been demonstrated 
through site-directed mutagenesis of amino acid residues lining the 
active site of certain PKSs [94-96]. In one case, Abe et al. [96] were 
able to perform site-directed mutagenesis on an octaketide producing 
PKS, thereby creating the mutant CHS’s G207A, G207T, G207M, 
G207L, G207F, and G207W. The mutagenesis of this single residue 
led to the formation of smaller polyketides (triketides to 
heptaketides). Site-directed mutagenesis of a CHS has also been 
shown to affect its starter molecule specificity. In 2002 Jez et al. [97] 
were able to create a type III PKS capable of using the previously 
unusable substrate N-methylanthraniloyl-CoA to produce a novel 
alkaloid. This was accomplished by a single point mutation, F215S, 
in the PKS. 
 
Concluding remarks and outlook 
 
With the increasing availability of plant genomic sequences, the 
repertoire of plant biosynthetic genes is continuously expanding. 
These biological parts are the starting point for the reconstruction of 
plant secondary metabolic pathways in microorganisms [3]. The 
success of a defined engineering approach greatly depends on the use 
of adequate synthetic enzymes. After establishing the pathway in the 
microbial host and demonstrating the production of the desired 
metabolite, the next step is to increase product yield to the point of 
economic viability. Yield improvement currently represents the 
greatest engineering challenge. Metabolic limitations and bottlenecks 
have to be identified, and should be considered from the perspective 
of the whole organism. A holistic approach including rational and 
computational analysis is fast becoming the norm, and is advisable 
before carrying out significant manipulation of metabolic pathways. 
Not only can such an approach inform planning design, it can also be 
used iteratively once physiological and yield data is available from 
initial metabolic systems. 
While informed engineering decisions are comparatively easy to 
make in the canonical model organisms, many promising host species 
currently lack sufficient characterisation to exploit fully [19,65,98]. 
Along with improved tools for genetic manipulation, as metabolic and 
regulatory data becomes available for novel hosts, more engineering 
will take place in these systems to take advantage of differences in 
their evolutionarily engineered metabolome. Such an expansion of 
host chassis, both highly engineered and naturally diverse, will 
undoubtedly complement the current molecular tuning of engineered 
plant polyketide pathways.  
Microbial production of plant polyketides is still at an early stage 
and is greatly limited by the availability of characterised biosynthetic 
genes and the lack of knowledge about pathway structures. Recent 
engineering efforts have focused on CHS and STS, with most of the 
PKS diversity barely touched. Given all the avenues for development 
available to researchers, there is significant room for the field to grow. 
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